Early Start Of Tenofovir Treatment Achieves Better Viral Suppression In Pregnant Women With A High HBV Viral Load: A Real-World Prospective Study

PURPOSE: To investigate whether tenofovir disoproxil fumarate (TDF) treatment that started from the second trimester had an advantage over TDF treatment that started from the third trimester. PATIENTS AND METHODS: Twenty 35-year-old pregnant women with hepatitis B virus (HBV) DNA >2×106 IU/mL wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Fan, Zhang, Wen-Tao, Lin, Ya-Yun, Wang, Wei-Min, Xu, Na, Bai, Gui-Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844215/
https://www.ncbi.nlm.nih.gov/pubmed/31807036
http://dx.doi.org/10.2147/IDR.S228982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844215/
https://www.ncbi.nlm.nih.gov/pubmed/31807036
http://dx.doi.org/10.2147/IDR.S228982

Ejemplares similares